echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Active Ingredient Products News > The Applications of Nicardipine hydrochloride

    The Applications of Nicardipine hydrochloride

    • Last Update: 2023-05-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Nicardipine hydrochloride is a calcium channel blocker drug that is used to treat hypertension and angina pectoris.
    It has a wide range of applications in the chemical industry, including as a pharmaceutical excipient, a research chemical, and as a building block for the synthesis of other chemicals.


    One of the primary applications of nicardipine hydrochloride in the chemical industry is as a pharmaceutical excipient.
    Excipients are chemicals that are added to pharmaceutical products to improve their efficacy, safety, or manufacturing process.
    Nicardipine hydrochloride is used as an excipient in various pharmaceutical formulations, including tablets, capsules, and suspensions.
    It is known to enhance the bioavailability of the active ingredients in these formulations by improving their solubility and permeability.


    Nicardipine hydrochloride is also used in research applications.
    It is a valuable tool for studying the mechanisms of calcium channel blockers and for understanding their effects on various physiological systems.
    Researchers use nicardipine hydrochloride to study the effects of calcium channel blockers on blood pressure, heart rate, and other cardiovascular parameters.
    It is also used in the study of the structure and function of calcium channels and in the development of new calcium channel blockers.


    In addition to its use as a pharmaceutical excipient and research chemical, nicardipine hydrochloride is also used as a building block for the synthesis of other chemicals.
    It is commonly used in the synthesis of other calcium channel blockers and in the production of other pharmaceuticals, including anti-hypertensive and anti-anginal agents.
    It is also used in the production of other organic compounds, such as dyes, fragrances, and flavorings.


    Nicardipine hydrochloride is synthesized by several chemical methods, including the following:


    • Hydrolysis of nicardipine base with hydrochloric acid
    • Hydrolysis of nicardipine hydrogen maleate with hydrochloric acid
    • Reaction of nicardipine base with chloroformic acid

    The commercial production of nicardipine hydrochloride typically involves the synthesis of the drug from nicardipine base, which is the starting material.
    Nicardipine base is synthesized from the reaction of diphenylamine with oxalic acid, followed by dehydrogenation of the resulting diphenyl oxalate.
    The synthesis of nicardipine hydrochloride from nicardipine base involves treating the base with hydrochloric acid, followed by purification of the resulting hydrochloride salt.


    The synthesis of nicardipine hydrochloride is a multi-step process that involves several chemical reactions and purification steps.
    The entire process is carefully monitored to ensure that the final product meets the required purity and quality standards.
    The final product is packaged in various forms, including powders, granules, and tablets, and is ready for use in pharmaceutical and research applications.


    In conclusion, nicardipine hydrochloride is a versatile compound with a wide range of applications in the chemical industry.
    It is used as a pharmaceutical excipient, research chemical, and building block for the synthesis of other chemicals.
    Its unique properties and chemical reactivity make it a valuable tool for studying the mechanisms of calcium channel blockers and for developing new drugs to treat hypertension and angina pectoris.
    With ongoing research and development, nicardipine hydrochloride is likely to continue to play an important role in the treatment of cardiovascular disease and in the development of new pharmaceuticals.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.